Geode Capital Management, LLC Surmodics Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Surmodics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 324,560 shares of SRDX stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

324,560

Previous 324,044 0.16%

Holding current value

$12.6 Million

Previous $13.6 Million 7.61%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$38.47 - $42.24 $19,850 - $21,795	516 Added 0.16%	324,560 $12.6 Million
Q2 2024 Aug 09, 2024	BUY	$25.39 - $42.1 $403,624 - $669,263	15,897 Added 5.16%	324,044 $13.6 Million
Q1 2024 May 13, 2024	BUY	$27.44 - $35.56 $243,612 - $315,701	8,878 Added 2.97%	308,147 $9.04 Million
Q4 2023 Feb 13, 2024	BUY	$28.47 - $38.49 $398,893 - $539,283	14,011 Added 4.91%	299,269 $10.9 Million
Q3 2023 Nov 13, 2023	BUY	$28.28 - $38.36 $251,267 - $340,828	8,885 Added 3.21%	285,258 $9.15 Million
Q2 2023 Aug 11, 2023	BUY	$17.67 - $31.31 $203,770 - $361,066	11,532 Added 4.35%	276,373 $8.65 Million
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $229,833 - $516,822	13,417 Added 5.34%	264,841 $6.03 Million
Q4 2022 Feb 13, 2023	BUY	$29.44 - $37.31 $123,618 - $156,664	4,199 Added 1.7%	251,424 $8.58 Million
Q3 2022 Nov 14, 2022	BUY	$28.84 - $38.92 $91,999 - $124,154	3,190 Added 1.31%	247,225 $7.52 Million
Q2 2022 Aug 12, 2022	BUY	$33.25 - $45.11 $60,382 - $81,919	1,816 Added 0.75%	244,035 $9.09 Million
Q1 2022 May 13, 2022	SELL	$40.68 - $49.72 $2.57 Million - $3.14 Million	-63,205 Reduced 20.69%	242,219 $11 Million
Q4 2021 Feb 11, 2022	SELL	$43.21 - $57.6 $57,901 - $77,184	-1,340 Reduced 0.44%	305,424 $14.7 Million
Q3 2021 Nov 12, 2021	BUY	$52.8 - $60.32 $463,689 - $529,730	8,782 Added 2.95%	306,764 $17.1 Million
Q2 2021 Aug 13, 2021	BUY	$51.29 - $59.15 $294,814 - $339,994	5,748 Added 1.97%	297,982 $16.2 Million
Q1 2021 May 12, 2021	BUY	$42.18 - $56.07 $1.21 Million - $1.61 Million	28,658 Added 10.87%	292,234 $16.4 Million
Q4 2020 Feb 12, 2021	BUY	$35.18 - $43.52 $33,913 - $41,953	964 Added 0.37%	263,576 $11.5 Million
Q3 2020 Nov 13, 2020	BUY	$37.98 - $48.72 $254,314 - $326,229	6,696 Added 2.62%	262,612 $10.2 Million
Q2 2020 Aug 13, 2020	BUY	$31.07 - $44.74 $189,340 - $272,645	6,094 Added 2.44%	255,916 $11.1 Million
Q1 2020 May 14, 2020	SELL	$22.46 - $42.24 $182,397 - $343,031	-8,121 Reduced 3.15%	249,822 $8.32 Million
Q4 2019 Feb 13, 2020	BUY	$39.01 - $47.51 $72,051 - $87,750	1,847 Added 0.72%	257,943 $10.7 Million
Q3 2019 Nov 12, 2019	BUY	$38.66 - $47.41 $426,419 - $522,932	11,030 Added 4.5%	256,096 $11.7 Million
Q2 2019 Aug 14, 2019	SELL	$38.23 - $47.43 $281,602 - $349,369	-7,366 Reduced 2.92%	245,066 $10.6 Million
Q1 2019 May 14, 2019	BUY	$41.26 - $58.35 $847,893 - $1.2 Million	20,550 Added 8.86%	252,432 $11 Million
Q4 2018 Feb 13, 2019	SELL	$44.93 - $73.38 $390,980 - $638,552	-8,702 Reduced 3.62%	231,882 $11 Million
Q3 2018 Nov 13, 2018	BUY	$56.85 - $80.35 $2.9 Million - $4.1 Million	50,968 Added 26.88%	240,584 $18 Million
Q2 2018 Aug 14, 2018	BUY	$35.85 - $57.05 $2.01 Million - $3.2 Million	56,123 Added 42.04%	189,616 $10.5 Million
Q1 2018 May 15, 2018	BUY	$27.0 - $38.5 $14,256 - $20,328	528 Added 0.4%	133,493 $5.08 Million
Q4 2017 Feb 13, 2018	SELL	$28.0 - $33.2 $333,984 - $396,009	-11,928 Reduced 8.23%	132,965 $3.72 Million
Q3 2017 Nov 14, 2017	SELL	$24.5 - $31.1 $404,862 - $513,927	-16,525 Reduced 10.24%	144,893 $4.49 Million
Q2 2017 Aug 14, 2017	BUY	N/A	161,418	161,418 $4.54 Million

Others Institutions Holding SRDX

# of Institutions

126

Shares Held

11.7M

Call Options Held

1.4K

Put Options Held

8.6K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $542M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Surmodics Inc Transaction History